Format

Send to

Choose Destination
Oncogenesis. 2016 Nov 21;5(11):e270. doi: 10.1038/oncsis.2016.71.

Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair.

Author information

1
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
2
First Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
3
Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
4
CONARIS Research Institute AG, Kiel, Germany.
5
Ferring Pharmaceuticals A/S, Copenhagen, Denmark.
6
Institute of Biochemistry, Kiel University, Kiel, Germany.

Abstract

Inflammatory bowel disease is characterized by disturbed cytokine signalling in the mucosa. Inhibition of the proinflammatory interleukin (IL)-6 pathway is a promising new therapeutic strategy, but safety concerns arise as IL-6 signalling also contributes to epithelial repair of the intestinal mucosa. To which extent IL-6 classic or trans-signalling contributes to intestinal repair remains elusive. We tested the influence of IL-6 classic signalling on intestinal repair and proliferation. Whereas IL-6 induced STAT3 phosphorylation in the colonic cancer cell lines, primary non-malignant intestinal organoids did not respond to IL-6 classic signalling. Mice deficient in intestinal IL-6R (IL-6RΔIEC mice) did not display increased susceptibility to acute dextran sulfate sodium (DSS)-induced colitis. In the azoxymethane DSS model IL-6RΔIEC mice were not protected from inflammation-induced carcinogenesis but showed comparable tumor load to wild-type mice. These data indicate that classic signalling is not the major pathway to transduce IL-6 stimuli into the intestinal epithelium.

Conflict of interest statement

GHW is employed by CONARIS Research Institute AG (a company commercially developing sgp130Fc proteins); SS and SR-J are shareholders of CONARIS, and both are inventors of patents owned by CONARIS. The other authors declare no conflict of interest.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center